UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Das 1 × 1 des Zeitmanagement

Seiwert, L. J

12. Auflage., 1989

Volltextzugriff (PDF)

ABC of practice management: A--work time and time management (2)

Die Quintessenz, 1990-03, Vol.41 (3), p.479

1990

Volltextzugriff (PDF)

ABC of practice management. A--work time and time management

Die Quintessenz, 1990-02, Vol.41 (2), p.283

1990

Volltextzugriff (PDF)

OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer

Annals of oncology, 2019-02, Vol.30 (2), p.297-302

2019

Volltextzugriff (PDF)

Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy

Annals of oncology, 2019-01, Vol.30 (1), p.68-75

2019

Volltextzugriff (PDF)

Antifibrotic activities of pirfenidone in animal models

European respiratory review, 2011-06, Vol.20 (120), p.85-97

2011

Volltextzugriff (PDF)

Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis

Nature genetics, 2013-06, Vol.45 (6), p.613-620

2013

Volltextzugriff (PDF)

Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Head and Neck Cancer

Clinical cancer research, 2019-09, Vol.25 (17), p.5315-5328

2019

Volltextzugriff (PDF)

Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing

Annals of oncology, 2015-06, Vol.26 (6), p.1216-1223

2015

Volltextzugriff (PDF)

Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis

JAMA : the journal of the American Medical Association, 2013-06, Vol.309 (21), p.2232

2013

Volltextzugriff (PDF)

Response-adapted volume de-escalation (RAVD) in locally advanced head and neck cancer

Annals of oncology, 2016-05, Vol.27 (5), p.908-913

2016

Volltextzugriff (PDF)

OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer

Annals of oncology, 2019-10, Vol.30 (10), p.1673-1673

2019

Volltextzugriff (PDF)

Zeitmanagement Mit Outlook: Die Zeit Im Griff Mit Microsoft Outlook 2010 - 2019 Strategien, Tipps und Techniken

aktualisierte Auflage, 2019

Volltextzugriff (PDF)

Functional analysis of c-met/hepatocyte growth factor pathway in malignant pleural mesothelioma

Cancer research (Chicago, Ill.), 2006, Vol.66 (1), p.352-361

2006

Volltextzugriff (PDF)

The effects of two fish predators on Wood Frog ( Lithobates sylvaticus ) tadpoles in a subarctic wetland: Hudson Bay Lowlands, Canada

Canadian journal of zoology, 2013-12, Vol.91 (12), p.866-871

2013

Volltextzugriff (PDF)

Phase I Study of Apitolisib (GDC-0980), Dual Phosphatidylinositol-3-Kinase and Mammalian Target of Rapamycin Kinase Inhibitor, in Patients with Advanced Solid Tumors

Clinical cancer research, 2016-06, Vol.22 (12), p.2874-2884

2016

Volltextzugriff (PDF)

On the generation of a foam film during a topological rearrangement

Journal of fluid mechanics, 2015-01, Vol.763, p.286-301

2015

Volltextzugriff (PDF)

Discovery of Danoprevir (ITMN-191/R7227), a Highly Selective and Potent Inhibitor of Hepatitis C Virus (HCV) NS3/4A Protease

Journal of medicinal chemistry, 2014-03, Vol.57 (5), p.1753-1769

2014

Volltextzugriff (PDF)

Biomarkers predictive of response to pembrolizumab in head and neck cancer

Cancer medicine (Malden, MA), 2023-03, Vol.12 (6), p.6603-6614

2023

Volltextzugriff (PDF)

A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab‐resistant head and neck cancer: The MAESTRO study

Cancer, 2020-07, Vol.126 (14), p.3237-3243

2020

Volltextzugriff (PDF)

Treatment De-intensification for HPV-Positive Oropharynx Cancer: What Is Currently Acceptable?

Journal of clinical oncology, 2021-08, Vol.39 (24), p.2732-2733

2021

Volltextzugriff (PDF)

A Phase 1 Dose-escalation and Expansion Study of CUE-101, Given As Monotherapy in 3rd Line and in Combination with Pembrolizumab in 1st Line Recurrent/Metastatic (R/M) HPV16+ Head and Neck Cancer Patients

International journal of radiation oncology, biology, physics, 2024-04, Vol.118 (5), p.e87-e87

2024

Volltextzugriff (PDF)

Comparison of outcomes of locoregionally advanced oropharyngeal and non-oropharyngeal squamous cell carcinoma over two decades

Annals of oncology, 2015-01, Vol.26 (1), p.198-205

2015

Volltextzugriff (PDF)

A systematic approach for designing a HBM Pilot Study for Europe

International journal of hygiene and environmental health, 2014-03, Vol.217 (2-3), p.312-322

2014

Volltextzugriff (PDF)

1 – 25 von 84

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(69)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(37)
Life Sciences & Biomedicine
(35)
Humans
(31)
Female
(17)
Male
(16)
Oncology
(16)
Middle Aged
(15)
Adult
(13)
Aged
(13)
Biological And Medical Sciences
(10)
Medical Sciences
(8)
Aged, 80 And Over
(7)
Public, Environmental & Occupational Health
(7)
Animals
(6)
Head And Neck Neoplasms - Drug Therapy
(6)
Hematology, Oncology And Palliative Medicine
(6)
Environmental Monitoring - Methods
(5)
Environmental Sciences
(5)
Environmental Sciences & Ecology
(5)
Europe
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Das 1 × 1 des Zeitmanagement

ABC of practice management: A--work time and time management (2)

ABC of practice management. A--work time and time management

OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer

Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy

Antifibrotic activities of pirfenidone in animal models

Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis

Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Head and Neck Cancer

Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing

Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis

Response-adapted volume de-escalation (RAVD) in locally advanced head and neck cancer

OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer

Zeitmanagement Mit Outlook: Die Zeit Im Griff Mit Microsoft Outlook 2010 - 2019 Strategien, Tipps und Techniken

Functional analysis of c-met/hepatocyte growth factor pathway in malignant pleural mesothelioma

The effects of two fish predators on Wood Frog ( Lithobates sylvaticus ) tadpoles in a subarctic wetland: Hudson Bay Lowlands, Canada

Phase I Study of Apitolisib (GDC-0980), Dual Phosphatidylinositol-3-Kinase and Mammalian Target of Rapamycin Kinase Inhibitor, in Patients with Advanced Solid Tumors

On the generation of a foam film during a topological rearrangement

Discovery of Danoprevir (ITMN-191/R7227), a Highly Selective and Potent Inhibitor of Hepatitis C Virus (HCV) NS3/4A Protease

Biomarkers predictive of response to pembrolizumab in head and neck cancer

A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab‐resistant head and neck cancer: The MAESTRO study

Treatment De-intensification for HPV-Positive Oropharynx Cancer: What Is Currently Acceptable?

Paxillin Is a Target for Somatic Mutations in Lung Cancer : Implications for Cell Growth and Invasion

A Phase 1 Dose-escalation and Expansion Study of CUE-101, Given As Monotherapy in 3rd Line and in Combination with Pembrolizumab in 1st Line Recurrent/Metastatic (R/M) HPV16+ Head and Neck Cancer Patients

Comparison of outcomes of locoregionally advanced oropharyngeal and non-oropharyngeal squamous cell carcinoma over two decades

A systematic approach for designing a HBM Pilot Study for Europe

Suchergebnisse filtern